Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil
- PMID: 27861618
- PMCID: PMC5115742
- DOI: 10.1371/journal.pone.0166475
Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil
Abstract
Neisseria meningitidis is a commensal bacterium of the human nasopharynx. In rare cases, it penetrates the mucosa, entering the blood stream and causing various forms of disease. Meningococcal conjugate vaccines can prevent invasive disease not only by direct effect in vaccinated individuals but also by herd protection, preventing acquisition of carriage, which interrupts transmission and leads to protection of unvaccinated persons. In 2010 in Salvador, Brazil, an outbreak of group C meningococcal disease led to a mass meningococcal serogroup C conjugate vaccination drive, targeting those <5 and 10-24 years of age. The present study aimed to estimate the prevalence of and identify factors associated with N. meningitidis carriage among adolescents from Salvador, Brazil, in the post-vaccination period. In spring 2014, we performed a cross-sectional study involving 1,200 public school students aged 11-19 years old. Oropharyngeal swabs were collected to identify N. meningitidis. Of the 59 colonized participants, 36 (61.0%) carried non-groupable N. meningitidis, while genogroup B (11.9%), Y (8.5%), E (6.8%), Z (5.1%), C (3.4%), and W (3.4%) were also detected. The overall prevalence of N. meningitidis carriage was 4.9% (95% confidence interval [CI], 3.6-6.1%); the prevalence of N. meningitidis genogroup C was 0.17% (95% CI, 0.0-0.40%). There was no difference by age. Factors associated with carriage were having only one, shared, bedroom in the household (PR, 2.02; 95% CI, 0.99-4.12, p = 0.05); the mother being the only smoker in the home (PR, 2.48; 95% CI, 1.16-5.29; p = 0.01); and going to pubs/parties more than 5 times/month (PR, 2.61; 95% CI, 1.38-4.92; p = 0.02). Our findings show that the N. meningitidis carriage rate in adolescents from Salvador, Bahia, is low and is potentially influenced by the low prevalence of N. meningitidis genogroup C. However, continued surveillance is important to identify changes in the dynamics of N. meningitidis, including the emergence of diseases due to a non-C serogroup.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.Vaccine. 2020 Mar 23;38(14):2995-3002. doi: 10.1016/j.vaccine.2020.02.050. Epub 2020 Feb 28. Vaccine. 2020. PMID: 32115294
-
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.BMC Infect Dis. 2016 Nov 4;16(1):639. doi: 10.1186/s12879-016-1975-3. BMC Infect Dis. 2016. PMID: 27814682 Free PMC article.
-
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.N Engl J Med. 2020 Jan 23;382(4):318-327. doi: 10.1056/NEJMoa1900236. N Engl J Med. 2020. PMID: 31971677 Clinical Trial.
-
Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.Hum Vaccin Immunother. 2018 May 4;14(5):1118-1130. doi: 10.1080/21645515.2018.1454570. Epub 2018 May 9. Hum Vaccin Immunother. 2018. PMID: 29565712 Free PMC article. Review.
-
An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.Expert Rev Anti Infect Ther. 2017 Jul;15(7):689-701. doi: 10.1080/14787210.2017.1333422. Epub 2017 May 29. Expert Rev Anti Infect Ther. 2017. PMID: 28524748 Review.
Cited by
-
Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the Literature.Infect Dis Ther. 2020 Jun;9(2):209-240. doi: 10.1007/s40121-020-00291-9. Epub 2020 Apr 2. Infect Dis Ther. 2020. PMID: 32242281 Free PMC article. Review.
-
A critical analysis of serogroup B meningococcal disease burden in Brazil (2001-2015): implications for public health decisions.Hum Vaccin Immunother. 2020 Aug 2;16(8):1945-1950. doi: 10.1080/21645515.2019.1700710. Epub 2020 Jan 17. Hum Vaccin Immunother. 2020. PMID: 31951784 Free PMC article.
-
Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial.Lancet Microbe. 2022 Dec;3(12):e931-e943. doi: 10.1016/S2666-5247(22)00283-X. Lancet Microbe. 2022. PMID: 36462524 Free PMC article. Clinical Trial.
-
Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.Hum Vaccin Immunother. 2018 May 4;14(5):1131-1137. doi: 10.1080/21645515.2017.1415682. Epub 2018 Jan 30. Hum Vaccin Immunother. 2018. PMID: 29236585 Free PMC article.
-
Comprehensive analysis of the Global Burden and epidemiological trends of meningitis from 1990 to 2021.Infection. 2025 Apr;53(2):693-709. doi: 10.1007/s15010-025-02483-2. Epub 2025 Mar 3. Infection. 2025. PMID: 40029588
References
-
- Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012; 30 Suppl 2: B26–36. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials